Your browser doesn't support javascript.
loading
Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance.
Englinger, B; Mair, M; Miklos, W; Pirker, C; Mohr, T; van Schoonhoven, S; Lötsch, D; Körner, W; Ferk, F; Knasmüller, S; Heffeter, P; Keppler, B K; Grusch, M; Berger, W.
Afiliação
  • Englinger B; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Mair M; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Miklos W; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Pirker C; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Mohr T; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • van Schoonhoven S; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Lötsch D; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Körner W; Department of Environmental Geosciences, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.
  • Ferk F; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Knasmüller S; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Heffeter P; Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
  • Keppler BK; Research Platform 'Translational Cancer Therapy Research', University of Vienna and Medical University of Vienna, Waehringer Str. 42, A-1090 Vienna, Austria.
  • Grusch M; Research Platform 'Translational Cancer Therapy Research', University of Vienna and Medical University of Vienna, Waehringer Str. 42, A-1090 Vienna, Austria.
  • Berger W; Institute of Inorganic Chemistry, University of Vienna, Waehringer Str. 42, A-1090 Vienna, Austria.
Br J Cancer ; 116(4): 489-500, 2017 Feb 14.
Article em En | MEDLINE | ID: mdl-28095394
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Tetra-Hidroisoquinolinas / Proteínas Culina / Dioxóis Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Tetra-Hidroisoquinolinas / Proteínas Culina / Dioxóis Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria